MERIT MEDICAL SYSTEMS INCMMSIEarnings & Financial Report
Merit Medical Systems Inc. is a global medical device firm that designs, manufactures, and markets a broad portfolio of interventional and diagnostic products used across cardiology, radiology, oncology, endoscopy, and critical care segments. It primarily serves hospitals, clinics, and healthcare providers worldwide, focusing on minimally invasive solutions that enhance patient outcomes and streamline clinical workflows.
MMSI Q1 FY2026 Key Financial Metrics
Revenue
$381.9M
Gross Profit
$184.8M
Operating Profit
$44.2M
Net Profit
$41.0M
Gross Margin
48.4%
Operating Margin
11.6%
Net Margin
10.7%
YoY Growth
7.5%
EPS
$0.68
MERIT MEDICAL SYSTEMS INC Q1 FY2026 Financial Summary
MERIT MEDICAL SYSTEMS INC reported revenue of $381.9M (up 7.5% YoY) for Q1 FY2026, with a net profit of $41.0M (up 36.0% YoY) (10.7% margin). Cost of goods sold was $197.1M, operating expenses totaled $140.6M.
Key Financial Metrics
| Total Revenue | $381.9M |
|---|---|
| Net Profit | $41.0M |
| Gross Margin | 48.4% |
| Operating Margin | 11.6% |
| Report Period | Q1 FY2026 |
MERIT MEDICAL SYSTEMS INC Annual Revenue by Year
MERIT MEDICAL SYSTEMS INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.5B).
MERIT MEDICAL SYSTEMS INC Quarterly Revenue & Net Profit History
MERIT MEDICAL SYSTEMS INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $381.9M | +7.5% | $41.0M | 10.7% |
| Q4 FY2025 | $393.9M | +10.9% | $38.0M | 9.6% |
| Q3 FY2025 | $384.2M | +13.0% | $27.8M | 7.2% |
| Q2 FY2025 | $382.5M | +13.2% | $32.6M | 8.5% |
| Q1 FY2025 | $355.4M | +9.8% | $30.1M | 8.5% |
| Q4 FY2024 | $355.2M | +9.4% | $27.9M | 7.9% |
| Q3 FY2024 | $339.8M | +7.8% | $28.4M | 8.4% |
| Q2 FY2024 | $338.0M | +5.6% | $35.7M | 10.6% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $338.0M | $339.8M | $355.2M | $355.4M | $382.5M | $384.2M | $393.9M | $381.9M |
| YoY Growth | 5.6% | 7.8% | 9.4% | 9.8% | 13.2% | 13.0% | 10.9% | 7.5% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.37B | $2.38B | $2.42B | $2.47B | $2.59B | $2.63B | $2.69B | $2.72B |
| Liabilities | $1.09B | $1.05B | $1.04B | $1.04B | $1.10B | $1.10B | $1.10B | $1.09B |
| Equity | $1.28B | $1.32B | $1.38B | $1.43B | $1.49B | $1.53B | $1.58B | $1.63B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $68.5M | $47.3M | $68.7M | $40.6M | $83.3M | $75.0M | $98.5M |